Arena Pharmaceuticals - Daily Digest

Posted on 06/15/2012 by Allen Bersch


NEW YORK (AVAFIN) -- A record number of Arena Pharmaceuticals call contracts were traded during the busy trading session. There were 3.3 call contracts traded for each put contract yielding a 0.30 put/call ratio where 13,481 put and 45,015 call contracts exchanged hands.

View Options Trading Activities

Investors use options to manage risk and to speculate on price changes. Options can provide significant leverage if the stock moves in the right direction but aslo end up worthless if it doesn't.

Shares of Arena Pharmaceuticals edged up $0.32 (+3.96%) to $8.40. The price of the stock ranged between a low of $8.10 and $8.47 respectively. The trading volume of 23M is above the 90 day average volume of 17M shares. The technical momentum Relative Strength Index indicator shows overbought conditions. ARNA is trading above the 50 day moving average. The stock's 52 week low is $1.23 and 52 week high is $8.65. To date, the stock has gained 26.89% within the last week.

Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative therapies offering medical advances and new options for patients.

Market Snapshot (06/15/2012)
  SPX 1342.22 13.12 0.99%
  DOW 12764.2 112.30 0.89%
  NASDAQ 2872.8 36.47 1.29%
  VIX 21.31 -0.37 -1.71%

:: Market Movers ::

:: Technical Alerts ::

:: Candle Stick Alerts ::

:: Chart Patterns ::

:: Options Advisory Center ::

:: Block Trades Review ::

:: Trade Flow Analysis ::